Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation
Objective: To update and extend a 2006 report on the clinical effectiveness and cost-effectiveness of adefovir dipivoxil (ADV) and pegylated interferon alpha (PEG-?) for the treatment of chronic hepatitis B (CHB). Data sources: Thirteen bibliographic databases were searched including MEDLINE, EMBAS...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2009.
|
| Subjects: | |
| Online Access: | Get fulltext |